Analysts/Investors Meeting & Results Calendar
Results on October 25: Tech Mahindra, HDFC Asset Management Company, Aditya Birla Sun Life AMC, ANG Lifesciences India, Aurionpro Solutions, Ceat, Coforge, Colgate-Palmolive (India), CSB Bank, Dwarikesh Sugar Industries, Gujarat Mineral Development Corporation, Goodluck India, Home First Finance Company India, ICRA, Indus Towers, Jagran Prakashan, Kansai Nerolac Paints, Karda Constructions, LKP Securities, Maharashtra Scooters, Mangalam Organics, Newgen Software Technologies, Orient Cement, Prakash Industries, Quick Heal Technologies, Ramco Cements, Shriram Asset Management, SRF, Suven Life Sciences, and Welcure Drugs & Pharmaceuticals will release September quarter earnings on October 25.
Investors Meeting Schedule:
Metropolis Healthcare: The company's officials will meet investors on October 25, on acquisition of Hitech Diagnostic Centre.
Kirloskar Ferrous Industries: The company's officials will meet investors and analysts on October 25, to discuss financial results.
Dr Lal PathLabs: The company's officials will meet investors and analysts on October 27, to discuss financial and operating performance.
Kansai Nerolac Paints: The company's officials will meet investors and analysts on October 27, to discuss Q2FY2021-22 financial results.
Balaji Amines: The company's officials will meet investors and analysts on October 28, to discuss Q2 FY22 earnings.
Embassy Office Parks REIT: The company's officials will meet analysts and investors on October 29, to discuss financial results.
V-Guard Industries: The company's officials will meet investors and analysts on October 29, to discuss earnings.
Gail (India): The company's officials will meet investors on October 29, to discuss financial results.
ADF Foods: The company's officials will meet analysts and investors on November 1 post earnings.
JK Lakshmi Cement: The company's officials will meet analysts and investors on November 1, to discuss company's Q2 results.
Stocks in News
Reliance Industries: The company reported sharply higher consolidated profit at Rs 15,479 crore in Q2FY22 against Rs 10,602 crore in Q2FY21, revenue jumped to Rs 1,74,104 crore from Rs 1,16,195 crore YoY.
ICICI Bank: The bank reported sharply higher standalone profit at Rs 5,511 crore in Q2FY22 against Rs 4,251.3 crore in Q2FY21, net interest income jumped to Rs 11,690 crore from Rs 9,366 crore YoY.
ABB Power Products and Systems India: The company reported sharply higher profit at Rs 34.3 crore in Q2CY21 against Rs 4.8 crore in Q3CY20, revenue fell to Rs 850.6 crore from Rs 946.3 crore YoY. Order intake was at Rs 979 crore in Q3CY21, up from Rs 890.2 crore in Q3CY20.
Tata Consumer Products: The company reported higher consolidated profit at Rs 261.4 crore in Q2FY22 against Rs 234.3 crore in Q2FY21, revenue increased to Rs 3,033.12 crore from Rs 2781.34 crore YoY.
Gland Pharma: The company reported sharply higher consolidated profit at Rs 302 crore in Q2FY22 against Rs 218 crore in Q2FY21, revenue jumped to Rs 1,080.5 crore from Rs 831.5 crore YoY.
Tata Elxsi: The company reported sharply higher profit at Rs 125.33 crore in Q2FY22 against Rs 78.87 crore in Q2FY21, revenue jumped to Rs 595.33 crore from Rs 430.17 crore YoY.